Take a lot of sick days? Who you know and where you live might be partly to blame
New research suggests that knowing people in high places may not always be good for your health. The culprit? Economic inequality.
Heat-resistant enzymes could produce more cost-effective drugs
A new study could change the way scientists look at one of the most essential enzymes in medicine in hopes of designing better and more cost-effective drugs in the future.
Viewing serotonin activating its receptor for the first time
A team of researchers have used high-powered microscopes to view serotonin activating its receptor for the first time. Images reveal molecular details about the receptor that could improve drug design..
Cisco ups the ante for 400G Ethernet with big-bandwidth data-center switches
Cisco has 400G Ethernet switches that fall into two camps: The Nexus 9000 family aimed at large enterprise networks and the 3400-S class for hyperscale users. (Insider Story)
Supply chain transparency needed to combat soaring insulin costs
Spiraling insulin costs have created a dangerous barrier for many people with diabetes who need to access lifesaving treatments. The Endocrine Society is calling on stakeholders across the supply chai..
Editing nature: A call for careful oversight of environmental gene editing
Researchers makes the case for a new global governance to assure a neutral and informed evaluation of the potential benefits and risks of gene editing. The complex nature of these technologies, they w..
Atomic path from insulator to metal messier than thought
Vanadium dioxide has the unusual ability to switch from electrical insulator to conductor at the low temperature of 152 degrees Fahrenheit. By optically triggering this phase transition and pinging it..
Quantum on the edge: Light shines on new pathway for quantum technology
Scientists have for the first time demonstrated the protection of correlated states between paired photons using the intriguing physical concept of topology. This experimental breakthrough opens a pat..
Long-term prognosis of Chagas patients improved with anti-parasite drug
Researchers have found that the anti-parasite drug benznidazole may improve the long-term prognoses of patients with chronic Chagas disease.
New study offers hope for patients suffering from a rare form of blindness
A new form of therapy may halt or even reverse a form of progressive vision loss that, until now, has inevitably led to blindness. This hyper-targeted approach offers hope to individuals living with s..